Status Acronym ISRCTN EudraCT NCT (clinicaltrials.gov) DRKS
Active CoCoNut NCT01821456

Cologne Cohort of Neutropenic Patients

Purpose / Objectives

Primary Outcome

Prospective cohort on the outcome of neutropenic patients (risk factors, therapy, treatment results).

Secondary Outcomes

Prospective cohort on the outcome of neutropenic patients (risk factors, therapy, treatment results).

Diagnosis

  • Infectious diseases in Hematology and Oncology
  • Infectious diseases: Others
  • Maligne Tumorerkrankung (English name missing)

Neutropenia

Target population

Inclusion criteria

All patients neutropenic for at least two consecutive days.

Exclusion criteria

none

Study design

  • Single center
  • Prospective

Documents (password protected)

Networks

Responsibilities in overall study

Sponsor

Infektiologie II

Sponsor representative

Univ.-Prof. Dr. med. Oliver A. Cornely

Univ.-Prof. Dr. med. Jörg Janne Vehreschild

(National) Coordinating Investigator

Univ.-Prof. Dr. med. Jörg Janne Vehreschild

Project management

Infektiologie II

Dr. Sebastian Wingen-Heimann

Data management

Infektiologie II

Dr. Sebastian Wingen-Heimann

Database development

Infektiologie II

Univ.-Prof. Dr. med. Jörg Janne Vehreschild